{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:45:18Z","timestamp":1760244318173,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102299","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:37:40Z","timestamp":1741174660000},"page":"102299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A glaucoma drainage implant functioning as a sanctuary site for vitreoretinal lymphoma"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-134X","authenticated-orcid":false,"given":"Debora H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Li-Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Chevez-Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Schefler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2025.102299_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma: a review","volume":"4","author":"Pulido","year":"2018","journal-title":"International Journal of Retina and Vitreous"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102299_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.survophthal.2021.03.004","article-title":"Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management","volume":"66","author":"Raval","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102299_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"issue":"0","key":"10.1016\/j.ajoc.2025.102299_bib4","article-title":"Primary vitreoretinal lymphoma: recent advances and literature review","volume":"4","author":"Giuffr\u00e8","year":"2020","journal-title":"Annals of Lymphoma"},{"issue":"17","key":"10.1016\/j.ajoc.2025.102299_bib5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102299_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo.2007.127928","article-title":"Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience","volume":"92","author":"Frenkel","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102299_bib7","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41433-021-01462-9","article-title":"Management of endophthalmitis related to glaucoma drainage devices: review of the literature and our experience","volume":"35","author":"Islam","year":"2021","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102299_bib8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/IAE.0000000000001329","article-title":"Infectious endophthalmitis after glaucoma drainage implant surgery: clinical features, microbial spectrum, and outcomes","volume":"37","author":"Zheng","year":"2017","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102299_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjo.2004.049015","article-title":"Endophthalmitis associated with the Ahmed glaucoma valve implant","volume":"89","author":"Al-Torbak","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102299_bib10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0161-6420(01)00598-X","article-title":"Late endophthalmitis associated with glaucoma drainage implants","volume":"108","author":"Gedde","year":"2001","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajoc.2025.102299_bib11","first-page":"733","article-title":"Endophthalmitis after placement of a Molteno implant","volume":"21","author":"Perkins","year":"1990","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ajoc.2025.102299_bib12","article-title":"Prompt vitrectomy for management of endophthalmitis in setting of unexposed glaucoma drainage implant","volume":"18","author":"Junttila","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102299_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12886-021-02136-6","article-title":"Corynebacterium ocular infection after Baerveldt glaucoma implant surgery: treatment involving immediate tube withdrawal and temporary subconjunctival tube placement: a case report","volume":"21","author":"Mitsui","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102299_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00061198-199708000-00002","article-title":"Propionibacterium endophthalmitis following Molteno tube repositioning","volume":"6","author":"Fanous","year":"1997","journal-title":"J Glaucoma"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102299_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1186\/s12885-021-08515-y","article-title":"Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study","volume":"21","author":"Scheichel","year":"2021","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102299_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/ceo.13304","article-title":"Emerging diagnostic tests for vitreoretinal lymphoma: a review","volume":"46","author":"Dawson","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102299_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ajo.2005.05.032","article-title":"Diagnostic testing of vitrectomy specimens","volume":"140","author":"Davis","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajoc.2025.102299_bib18","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.3390\/ijms12095684","article-title":"Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma","volume":"12","author":"Wang","year":"2011","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102299_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10384-012-0150-7","article-title":"Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma","volume":"56","author":"Kimura","year":"2012","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102299_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2004.05028.x","article-title":"Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment","volume":"126","author":"Hormigo","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajoc.2025.102299_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.649789","article-title":"Relapsed primary central nervous system lymphoma: current advances","volume":"11","author":"Tao","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102299_bib22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/annonc\/mdm340","article-title":"Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report","volume":"18","author":"Grimm","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102299_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/nan.12259","article-title":"Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas","volume":"42","author":"Nakamura","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102299_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/cas.14347","article-title":"Gene expression profiling of primary vitreoretinal lymphoma","volume":"111","author":"Arai","year":"2020","journal-title":"Cancer Sci"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102299_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ejh.13191","article-title":"CD79B mutations in primary vitreoretinal lymphoma: diagnostic and prognostic potential","volume":"102","author":"Yonese","year":"2019","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102299_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/neup.12405","article-title":"Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma","volume":"37","author":"Zheng","year":"2017","journal-title":"Neuropathology"},{"key":"10.1016\/j.ajoc.2025.102299_bib27","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41598-017-01998-5","article-title":"Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102299_bib28","article-title":"MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival: a single-center experience","volume":"3","author":"Curran","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102299_bib29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/mmr.2020.11186","article-title":"Prognostic value of MYD88 L265P mutation in diffuse large B cell lymphoma via droplet digital PCR","volume":"22","author":"Niu","year":"2020","journal-title":"Mol Med Rep"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:33Z","timestamp":1760145993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"alternative-id":["S2451993625000520"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102299","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A glaucoma drainage implant functioning as a sanctuary site for vitreoretinal lymphoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102299"}}